Cumawas, Dave Roland L.

HRN: 27-12-08  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2026
BENZYL PENICILLIN 5MU (VIAL)
04/22/2026
04/22/2026
IV
5 Million
PTOR
Excision Biopsy
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: